BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  MassBio Announces New VP of Programs & Global Affairs

  In this role, Elizabeth will oversee all planning and execution of the organization’s annual Signature Events, along with running MassBio’s economic development and global affairs department.

  December 14, 2017

   · 

  2 min read
• Pharm Country

  Pfizer Inc. Announces Pricing Terms of Private Exchange Offer for Its 6.500 Per Cent. Notes Due 2038 Open to Certain Investors and Related Tender Offer Open to All Investors

  The Exchange Offer will expire at 5:00 p.m. (New York time) today, December 14, 2017

  December 14, 2017

   · 

  18 min read
• Business

  Thrombolytic Science Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as a Non-Executive Board Member

  TSI today announced the appointment of Annalisa Jenkins, MBBS, FRCP, formerly President and CEO of Dimension Therapeutics, as a non-executive board member.

  December 14, 2017

   · 

  2 min read
• Complix Receives €0.5 Million Grant to Further Develop its Pipeline of Proprietary Cell Penetrating Alphabodies Against Intracellular Cancer Targets

  The grant will allow Complix to further develop its CPAB platform, which can generate CPABs based therapeutics with the unique ability to act on targets located inside the cytosol and the nucleus of human cancer cells.

  December 14, 2017

   · 

  3 min read
• Provecs Medical Announces Publication of Scientific Review of Gene Therapy in Oncology

  Provecs Medical GmbH, a cancer immunotherapy company developing novel treatments to modulate the tumor microenvironment, today announced the publication of a review highlighting the use of gene therapy approaches in immuno-oncology to address multiple targets with a single drug.

  December 14, 2017

   · 

  2 min read
• Drug Development

  Aura Biosciences Announces Publication of Preclinical Data Supporting AU-011’s Potent and Selective Anti-cancer Activity in Ocular Melanoma Tumors

  The data published today suggest that AU-011 may be further investigated as a novel first-line treatment option that can enable early intervention and potentially become the standard of care for patients with early-stage ocular melanoma.

  December 14, 2017

   · 

  4 min read
• Business

  Dimerix and Proteomics Partner to Improve Treatment of Chronic Kidney Disease

  Proteomics International and Dimerix will evaluate the performance of PromarkerD alongside DMX-200 in early phase clinical trials for chronic kidney disease.

  December 14, 2017

   · 

  2 min read
• Molecular Characterization of Circulating Tumor Cells isolated with GILUPI Technology from Prostate Cancer Patients

  GILUPI GmbH announces the recent publication of a clinical study demonstrating multiplex gene expression profiling of cTCs isolated in vivofrom high-risk prostate cancer patients by the use of GILUPI CellCollector.

  December 14, 2017

   · 

  1 min read
• Genetown

  Corindus Announces First Commercial Installation of CorPath GRX System Outside of U.S.

  Corindus will partner with Apex Heart Institute to develop a Global Center of Excellence to train interventional cardiologists on robotic-assisted percutaneous coronary interventions (PCI).

  December 14, 2017

   · 

  5 min read
• 

  INSIGHTEC Gets a $150M Boost From Koch Disruptive Technologies

  The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications.

  December 14, 2017

   · 

  4 min read